Downregulation of TMOD1 promotes cell motility and cell proliferation in cervical cancer cells

Lu,Fangjin; Cui,Dandan; Mu,Bin; Zhao,Lu; Mu,Ping

doi:10.3892/ol.2020.11410

Downregulation of TMOD1 promotes cell motility and cell proliferation in cervical cancer cells

Authors:
- Fangjin Lu
- Dandan Cui
- Bin Mu
- Lu Zhao
- Ping Mu
View Affiliations

Affiliations: Department of Pharmacology, Shenyang Medical College, Shenyang, Liaoning 110034, P.R. China, Department of Maternity, Shenyang Women and Children's Health Hospital, Shenyang, Liaoning 110014, P.R. China, Shanghai Zhaohui Pharmaceutical Co., Ltd., Shanghai 201900, P.R. China, Department of Biochemistry and Molecular Biology, Basic Medical School, Shenyang Medical College, Shenyang, Liaoning 110034, P.R. China
Published online on: February 19, 2020 https://doi.org/10.3892/ol.2020.11410
Pages: 3339-3348

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tropomodulin‑1 (TMOD1) is a key regulator of actin dynamics, which caps the pointed end of actin filaments. TMOD1 has been reported to be involved in several cellular processes, including neurite outgrowth, spine formation and cell migration. Increasing evidence demonstrates that TMOD1 is implicated in several aspects of cancer development. The present study aimed to investigate the role of TMOD1 in cervical cancer. HeLa and CaSki cell lines, derived from human cervical cancer, were used to evaluate the function of TMOD1. Cell motility was measured via a wound‑healing assay, with the TMOD1 short hairpin (sh)RNAs transfected cells. Subsequently, cell proliferation was assessed using low serum cell culture condition, while cell cycle distribution was analyzed via flow cytometry. The results demonstrated that downregulated TMOD1 promoted cell motility and proliferation, which is attributed to promotion of G1/S phase transition in HeLa and CaSki cells. Furthermore, it was indicated that co‑expression of shRNA resistant TMOD1 rescued these phenomena. The clinical data demonstrated that high TMOD1 expression is associated with good pathological status in patients with cervical cancer. Overall, the results of the present study indicated that TMOD1 may act as a tumor suppressor in cervical cancer, whereby its downregulated expression was demonstrated to have direct effects on cell motility and cell proliferation. These results provide new evidence for the prognostic prediction of cervical cancer, which may serve as a promising therapeutic strategy for patients with cervical cancer.

View Figures

View References

1	Pimple S, Mishra G and Shastri S: Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol. 28:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
2	GLOBOCAN 2012, . Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, World Health Organization.
3	Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN and Gaffney DK: Cervical cancer: A global health crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
4	Lippman SM and Hawk ET: Cancer prevention: From 1727 to milestones of the past 100 years. Cancer Res. 69:5269–5284. 2009. View Article : Google Scholar : PubMed/NCBI
5	Liu Y, Yu J, Qian L, Zhang H and Ma J: Extended field intensity-modulated radiotherapy plus concurrent nedaplatin treatment in cervical cancer. Oncol Lett. 11:3421–3427. 2016. View Article : Google Scholar : PubMed/NCBI
6	Duenas-Gonzaleza A, Cetina L, Coronel J and Gonzalez-Fierro A: The safety of drug treatments for cervical cancer. Expert Opin Drug Saf. 15:169–180. 2016. View Article : Google Scholar : PubMed/NCBI
7	Fischer RS and Fowler VM: Tropomodulins: Llife at the slow end. Trends Cell Biol. 13:593–601. 2003. View Article : Google Scholar : PubMed/NCBI
8	Gokhin DS and Fowler VM: Cytoplasmic gamma-actin and tropomodulin isoforms link to the sarcoplasmic reticulum in skeletal muscle fibers. J Cell Biol. 194:105–120. 2011. View Article : Google Scholar : PubMed/NCBI
9	Fath T, Fischer RS, Dehmelt L, Halpain S and Fowler VM: Tropomodulins are negative regulators of neurite outgrowth. Eur J Cell Biol. 90:291–300. 2011. View Article : Google Scholar : PubMed/NCBI
10	Fischer RS, Fritz-Six KL and Fowler VM: Pointed-end capping by tropomodulin3 negatively regulates endothelial cell motility. J Cell Biol. 161:371–380. 2003. View Article : Google Scholar : PubMed/NCBI
11	Nowak RB, Papoin J, Gokhin DS, Casu C, Rivella S, Lipton JM, Blanc L and Fowler VM: Tropomodulin 1 controls erythroblast enucleation via regulation of F-actin in the enucleosome. Blood. 130:1144–1155. 2017. View Article : Google Scholar : PubMed/NCBI
12	Rho SB, Chun T, Lee SH, Park K and Lee JH: The interaction between E-tropomodulin and thymosin beta-10 rescues tumor cells from thymosin beta-10 mediated apoptosis by restoring actin architecture. FEBS Lett. 557:57–63. 2004. View Article : Google Scholar : PubMed/NCBI
13	Ting SB, Deneault E, Hope K, Cellot S, Chagraoui J, Mayotte N, Dorn JF, Laverdure JP, Harvey M, Hawkins ED, et al: Asymmetric segregation and self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2. Blood. 119:2510–2522. 2012. View Article : Google Scholar : PubMed/NCBI
14	Ito-Kureha T, Koshikawa N, Yamamoto M, Semba K, Yamaguchi N, Yamamoto T, Seiki M and Inoue J: Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth. Cancer Res. 75:62–72. 2015. View Article : Google Scholar : PubMed/NCBI
15	Suzuki T, Kasamatsu A, Miyamoto I, Saito T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H and Uzawa K: Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer. Int J Oncol. 48:607–612. 2016. View Article : Google Scholar : PubMed/NCBI
16	Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, et al: Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: A large-scale meta-analysis. Lancet Oncol. 17:1363–1373. 2016. View Article : Google Scholar : PubMed/NCBI
17	Lu F, Zheng Y, Donkor PO, Zou P and Mu P: Downregulation of CREB promotes cell proliferation by mediating G1/S phase transition in hodgkin lymphoma. Oncol Res. 24:171–179. 2016. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Zhang CG, Huang JC, Liu T and Li XY: Anticancer effects of bishydroxycoumarin are mediated through apoptosis induction, cell migration inhibition and cell cycle arrest in human glioma cells. J BUON. 20:1592–1600. 2015.PubMed/NCBI
20	Schneider CA, Rasband WS and Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nature Methods. 9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
21	Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K and Takei Y: Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int J Cancer. 125:2978–2990. 2009. View Article : Google Scholar : PubMed/NCBI
22	Saha T, Guha D, Manna A, Panda AK, Bhat J, Chatterjee S and Sa G: G-actin guides p53 nuclear transport: Potential contribution of monomeric actin in altered localization of mutant p53. Sci Rep. 6:326262016. View Article : Google Scholar : PubMed/NCBI
23	Sadhukhan S, Sarkar K, Taylor M, Candotti F and Vyas YM: Nuclear role of WASp in gene transcription is uncoupled from its ARP2/3-dependent cytoplasmic role in actin polymerization. J Immunol. 193:150–160. 2014. View Article : Google Scholar : PubMed/NCBI
24	Weber A, Pennise CR, Babcock GG and Fowler VM: Tropomodulin caps the pointed ends of actin filaments. J Cell Biol. 127:1627–1635. 1994. View Article : Google Scholar : PubMed/NCBI
25	Moyer JD, Nowak RB, Kim NE, Larkin SK, Peters LL, Hartwig J, Kuypers FA and Fowle VM: Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton. Blood. 116:2590–2599. 2010. View Article : Google Scholar : PubMed/NCBI
26	Nowak RB, Fischer RS, Zoltoski RK, Kuszak JR and Fowler VM: Tropomodulin1 is required for membrane skeleton organization and hexagonal geometry of fiber cells in the mouse lens. J Cell Biol. 186:915–928. 2009. View Article : Google Scholar : PubMed/NCBI
27	Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E, Ponzoni M, Zamò A, Iqbal J, Piccaluga PP, et al: Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 120:1274–1281. 2012. View Article : Google Scholar : PubMed/NCBI
28	Heng YW and Koh CG: Actin cytoskeleton dynamics and the cell division cycle. Int J Biochem Cell Biol. 42:1622–1633. 2010. View Article : Google Scholar : PubMed/NCBI
29	Lee YJ and Keng PC: Studying the effects of actin cytoskeletal destabilization on cell cycle by cofilin overexpression. Mol Biotechnol. 31:1–10. 2005. View Article : Google Scholar : PubMed/NCBI
30	Moulding DA, Blundell MP, Spiller DG, White MR, Cory GO, Calle Y, Kempski H, Sinclair J, Ancliff PJ, Kinnon C, et al: Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia. J Exp Med. 204:2213–2224. 2007. View Article : Google Scholar : PubMed/NCBI
31	Lee K and Song K: Actin dysfunction activates ERK1/2 and delays entry into mitosis in mammalian cells. Cell Cycle. 6:1487–1495. 2007. View Article : Google Scholar : PubMed/NCBI
32	Gachet Y, Tournier S, Millar JB and Hyams JS: A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast. Nature. 412:352–355. 2001. View Article : Google Scholar : PubMed/NCBI
33	Sui Z, Nowak RB, Bacconi A, Kim NE, Liu H, Li J, Wickrema A, An XL and Fowler VM: Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver. Blood. 123:758–767. 2014. View Article : Google Scholar : PubMed/NCBI
34	Yamashiro S, Gokhin DS, Kimura S, Nowak RB and Fowler VM: Tropomodulins: Pointed-end capping proteins that regulate actin filament architecture in diverse cell types. Cytoskeleton (Hoboken). 69:337–370. 2012. View Article : Google Scholar : PubMed/NCBI
35	Pedraza N, Cemeli T, Monserrat MV, Garí E and Ferrezuelo F: Regulation of small GTPase activity by G1 cyclins. Small GTPases. 10:47–53. 2019. View Article : Google Scholar : PubMed/NCBI
36	Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, et al: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 8:18012017. View Article : Google Scholar : PubMed/NCBI